NTPDase activity in human lymphocytes is not affected by therapeutic doses of anti-HIV drugs - 30/11/11
, Maria R.C. Schetinger a, Claudio A.M. Leal a, Claudia de M. Bertoncheli b, Vera M. Morsch a
Corresponding author. Fax: +55 55 32208242.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 3 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
NTPDase (EC 3.6.1.5) is an enzyme that hydrolyzes extracellular nucleoside tri- and/or diphoshates forming AMP that can serve as a substrate for an ecto-5′-nucleotidase (EC 3.1.3.5) with liberation of adenosine, a modulator of vascular tone and inhibitor of platelet aggregation. These enzymes also occur in lymphocytes playing an important role in immune function. In this study, it was investigated if anti-HIV therapy could affect NTPDase activity in human lymphocytes. Samples of lymphocytes were incubated with different concentrations of anti-HIV drugs and NTPDase activity was determined by colorimetric assay with quantification of inorganic phosphate released. There is not significant difference of NTPDase activity among samples with therapeutic doses of anti-HIV drugs tested when compared with controls. NTPDase activity in peripheral human lymphocytes is not altered by anti-HIV therapy.
Le texte complet de cet article est disponible en PDF.Keywords : NTPDase, Anti-HIV drugs, Human lymphocytes
Plan
Vol 65 - N° 8
P. 594-596 - décembre 2011 Retour au numéro
Article précédent
- Inhibition of aldehyde dehydrogenase 2 activity enhances antimycin-induced rat cardiomyocytes apoptosis through activation of MAPK signaling pathway
- Peng Zhang, Danling Xu, Shijun Wang, Han Fu, Keqiang Wang, Yunzeng Zou, Aijun Sun, Junbo Ge
- Apolipoprotein E genotype as a most significant predictor of lipid response at lipid-lowering therapy: Mechanistic and clinical studies
- A.D. Dergunov
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?